Demoralization's link to depression and anxiety symptoms: A network analysis
Journal of Affective Disorders · 2025
DOI: 10.1016/j.jad.2024.12.045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Affective Disorders, 2025. Verfasst von Markus Ramm und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychosomatic Medicine and Psychotherapy, University Hospital Münster, Münster, Germany. Electronic address: markus.ramm@ukmuenster.de. Hauptthemen laut MEDLINE: Depression, Anxiety, Demoralization, COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
Demoralization represents a clinical syndrome conceptualized as maladaptive coping to a stressor associated with discouragement, feelings of hopelessness, helplessness, and a loss of meaning in life. It is a prevalent comorbidity in individuals with severe physical illnesses and affects a substantial proportion of the general population when facing global stressors like the COVID-19 pandemic. The main aim of the study was to test whether demoralization and features of depression and anxiety might reflect distinct entities within the general population, specifically in older adults, and to explore symptom interconnections, using a network psychometrics approach. The revised demoralization scale (DS-II) and the patient health questionnaire 4 (PHQ-4) were applied to a representative sample (N = 2434) from the German general population. Network structures were analyzed using exploratory graph analysis (EGA) to identify the most distinct symptom groupings and their relationships. Stability of networks and symptom groupings was tested using bootstrap procedures. EGA revealed unidimensionality within younger adulthood and a four-factor solution within older adults, reliably distinguishing PHQ-4 and DS-II items. The most central features of the network were worthlessness, pointlessness, helplessness, feeling trapped and low mood. Suicidal ideation was more closely related to DS-II worthlessness than to PHQ-4 items. The cross-sectional design and using PHQ-4 instead of more comprehensive measures of depression and anxiety were limitations. In conclusion, in general population, demoralization symptoms can be distinguished from lack of interest or pleasure and low mood. It might represent a valid psychological construct beyond clinical populations. Further investigation of diagnostic implications is encouraged.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychosomatic Medicine and Psychotherapy, University Hospital Münster, Münster, Germany. Electronic address: markus.ramm@ukmuenster.de.
- Department of Psychosomatic Medicine and Psychotherapy, University Hospital Münster, Münster, Germany.
- Department of Child and Adolescent Psychiatry/Psychotherapy, University Hospital Ulm, Center for Child Protection in Medicine in Baden-Württemberg, Germany.
- University Medical Center of the Johannes Gutenberg University Mainz, Department of Psychosomatic Medicine and Psychotherapy, Mainz, Germany; University of Leipzig Medical Center, Department of Medical Psychology and Me…
Zitieren
APA
Ramm, M., Schnabel, K., Jedamzik, J., Jürgens, L., Rassenhofer, M., Brähler, E., Heuft, G., & Conrad, R. (2025). Demoralization's link to depression and anxiety symptoms: A network analysis. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2024.12.045
Vancouver
Ramm M, Schnabel K, Jedamzik J, Jürgens L, Rassenhofer M, Brähler E, et al. Demoralization's link to depression and anxiety symptoms: A network analysis. Journal of Affective Disorders. 2025. doi:10.1016/j.jad.2024.12.045
BibTeX
@article{Ramm2025,
author = {Ramm, Markus and Schnabel, Kathrin and Jedamzik, Johanna and Jürgens, Lara and Rassenhofer, Miriam and Brähler, Elmar and Heuft, Gereon and Conrad, Rupert},
title = {Demoralization's link to depression and anxiety symptoms: A network analysis},
journal = {Journal of Affective Disorders},
year = {2025},
doi = {10.1016/j.jad.2024.12.045}
}
EUVIMED